SEC Comment Letter for NOVARTIS AG (NVS, NVSEF) (CIK 0001114448) (NVS) — Sep 16, 2009

NOVARTIS AG (NVS, NVSEF) (CIK 0001114448)
Date: Sept. 16, 2009 · CIK: 0001114448 · Accession: 0000000000-09-051583

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 001-15024

Date

September 1, 2009

Author

Not clearly detected

Form

UPLOAD

Company

NOVARTIS AG (NVS, NVSEF) (CIK 0001114448)

Letter

Via Facsimile and U.S. Mail Mail Stop 4720 September 1, 2009 Dr. Daniel Vasella, M.D. Chairman and Chief Executive Officer Novartis, Inc. Lichtstrasse 35 4056 Basel, Switzerland Re: Novartis, Inc. Form 20-F for the Fiscal Year Ended December 31, 2008 File No. 001-15024 Dear Dr. Vasella: We have completed our review of your Fo rm 20-F and related filings and have no further comments at this time. Sincerely,

Carlton E. Tartar Accounting Branch Chief

Show Raw Text

Via Facsimile and U.S. Mail Mail Stop 4720                                                                                                    September 1, 2009   Dr. Daniel Vasella, M.D. Chairman and Chief Executive Officer Novartis, Inc. Lichtstrasse 35 4056 Basel, Switzerland
Re: Novartis, Inc.
 Form 20-F for the Fiscal Year Ended December 31, 2008
File No. 001-15024
 Dear Dr. Vasella:
We have completed our review of your Fo rm 20-F and related filings and have no
further comments at this time.
 Sincerely,

Carlton E. Tartar Accounting Branch Chief

SecProbe.io